Screening for Opioid Misuse and Abuse in Chronic Pain Patients by Farris, Gloria Jean
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2017




Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Nursing Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been














This is to certify that the doctoral study by  
  
  
Gloria Farris  
  
  
has been found to be complete and satisfactory in all respects, and 
that any and all revisions required by   
the review committee have been made.  
  
  
Review Committee  
Dr. Catherine Garner, Committee Chairperson, Nursing Faculty  
Dr. Francisca Farrar, Committee Member, Nursing Faculty  






Chief Academic Officer 














Abstract    
Screening for Opioid Misuse and Abuse in Chronic Pain Patients   
by   
Gloria Farris   
   
MS, University of Alabama, 2005   
BS, University of Alabama, 1999   
   
   
Project Submitted in Partial Fulfillment   
Of the Requirements for the Degree of   
Doctor of Nursing Practice   
   
   
Walden University   
August 2017   
   
   
   
   
   
 
 
   
  
  
Abstract   
In 2012, opioid prescriptions exceeded 250 million, which is equivalent to providing a 
prescription to every adult in the United States. Prescription opioids have contributed to 
over 100,000 deaths since the late 1990s with the greatest impact among adults 35 
through 54 years of age. The purpose of this doctoral project was to introduce an 
evidence-based screening tool that will identify patients who are at risk of opioid misuse 
and aid in the development of the most effective treatment plan to manage chronic pain 
and avoid abuse. The Screener and Opioid Assessments for Patients with Pain (SOAPP), 
a screening tool, was given to 100 participants, both males and females between the ages 
of 25 and 65, in an outpatient pain clinic. The data collection method was a 
questionnaire consisting of 14 questions designed to predict behaviors of people using 
opioids for chronic pain. Participant questionnaire responses on the Likert-5-point scale 
of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), and 4 (Very Often) were totaled 
with a score of 7 or above indicating a high risk for abuse. Once the SOAPP data were 
obtained scores were calculated and grouped into categories of low or high risk for 
opioid misuse or abuse. Results indicated that 25% of the participants scored at high risk 
for opioid misuse (22% were female and 27% male) implying that there was a need for 
additional monitoring by the physician and nurse practitioner. The mean age for high 
risk was 51 and for low risk 54. Pain management providers play a crucial role in the 
effectiveness and success of the patient’s treatment. Positive social change may occur 
when assessment tools such as the SOAPP are used in the evaluation and management of 
patients with chronic pain and addiction.   
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Section 1: Introduction   
Introduction   
Pain is one of the major causes of disability, work loss, and health care cost in the 
United States (Hayden, Cartwright, Riley, and Vantulder, 2012). Patients with chronic 
pain are often seen in clinical settings devoted to pain management. There has been an 
increase in abuse and misuse of opioids for chronic pain patients in the United States   
(Manworren & Gilson, 2015). According to the National Institute of Health (NIH), over  
125 million people in the United States suffered with some type of pain (NIH, 2015). It is 
expected that 70% of those people treated their pain with opioids prescribed to a friend or 
family member (Arnstein, & St. Marie, 2010). Overprescribing of opioids for pain 
management has contributed to a noticeable increase in opioid addiction, death caused by 
overdose, and heroin use (American Academy of Orthopaedic Surgeons [AAOS], 2015).    
The clinical dilemma is how to treat chronic pain while avoiding opioid abuse and 
misuse. Sullivan, Korff, Banta-Green, Merrill, and Saunders (2012) describe deviant 
patient drug-related behaviors such as obtaining prescriptions from multiple providers, 
forging prescriptions, and increasing opioid dosages. These behaviors could potentially 
indicate addictive characteristics or a possible manifestation of poor pain control. 
According to the Obama Administration, prescription drug abuse has had an agonizing 
impact on individuals, families, healthcare providers, and law enforcement in the United 
States, and it is imperative to take action against this epidemic (The White House, Office 
of the Press Secretary, 2015).   
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Overprescribed opioid medications are becoming the most frequently misused 
controlled substances nationally (Stayner & Copenhaver, 2012). According to the Benzon, 
Liu, Fishman, & Cohen, (2011), pain related laws have not kept current with advances in 
medical and scientific understanding. The legislative bodies have created laws that are 
broad and general, with the expectation that they will be interpreted by the regulatory 
agencies. However, this has not been the case, and implications of overprescribing 
practices with opioids remains a concern.    
This practice improvement project will introduce the utilization of an 
evidencebased screening tool to assist providers in recognizing those at risk for opioid 
abuse or misuse and can also be used to help guide the development of the individualized 
plan of care for this patient population. This follows the recent work completed by the 
Choosing Wisely Campaign (2014) committee which recommends that healthcare 
providers not prescribe opioids until after discussing risks, such as addiction, with the 
client. Educating patients on risk factors increases their awareness of opioid abuse and 
allows the patient to become involved in their plan of care (American Society of  
Anesthesiologists [ASA],   
2014). Ultimately, it is the healthcare provider’s decision whether to prescribe opioids as 
well as the dosage when prescribed. Utilization of tools such as Screener and Opioid 
Assessments for Patients with Pain (SOAPP; Inflexxion, Inc., 2008) can assist in 
determining those who may be at risk of misuse and, subsequently, aid in the development 
of a treatment plan that will assist in the prevention of addictive behaviors that could 
promote misuse. This can contribute to the prevention and treatment of opioid abuse.   
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Problem Statement   
In 2012, opioid prescriptions exceeded 250 million, which is equivalent to 
providing one prescription to every adult in the United States (The White House, 2015). 
According to Franklin (2014), prescription opioids have contributed to over 100,000 
deaths since the late 1990s, with the greatest impact among adults 35 through 54 years of 
age. The shortage of physicians specializing in pain management has contributed to 
ineffective opioid prescribing practices (Harle, Bauer, Hosang, Cook, Hurley, and 
Fillingim, 2015). It is also noted that primary care doctors become distressed when trying 
to manage patients with chronic pain due to the worries about opioid abuse, misuse, and 
diversion (Harle et al., 2015). Primary care physicians have a limited amount of training in 
pain management (Jeffery, Butler, Stark, & Kane, 2011) and have time restraints when 
caring for patients with chronic pain (Abbo, Zhang, Zelder, and Huang, 2011), which 
plays a major role in effective pain management.    
The setting for this study is an outpatient pain clinic, which sees approximately 
6,000 patients yearly, averaging about 500 patients per month. The patients have been 
diagnosed with chronic pain and a majority are currently receiving opioids for pain 
management. With the concern over the rising number of deaths, abuse, and misuse of 
opioids, the need for a specific assessment tool was identified by the physician who is the 
key stakeholder. The utilization of a screening tool could be helpful in identifying patients 
at risk for addictive behaviors which would alert clinicians to monitor patients more 
closely and provide specific education or different interventions. Based on the clinician’s 
findings, they may recognize a need to alter their plan of care including  dosage 
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adjustments, thereby producing better pain management results and a decrease in the 
potential misuse of opioids.    
Background   
The institutions referenced to address this problem are the Centers for Disease   
Control and Prevention (CDC) and Department of Health and Human Services (HHS). 
According to the CDC, there has been an increase in deaths due to opioid overdose. It has 
been estimated that 6 to 8 million Americans use opioids for noncancer pain (Baldini, Von 
Korff, & Lin, 2012). The CDC will invest $8.5 million on (a) the development of tools 
and resources to help inform providers about effective opioid prescribing; (b) track data 
on prescribing trends; (c) research, develop, and evaluate clinical quality improvement 
measurements and programs on opioids prescribing; and (d) improve public understanding 
of the risks and benefits of opioid use (The White House, 2015). The HHS will invest 
$100 million in Affordable Care Act funding to focus on the assurance of prescribing a 
product of suboxone and narcan for the treatment of opioid dependency. HHS plans to 
make these medications accessible to community health centers across the country (USG, 
2015).   
Opioid dependence continues to be a chronic problem not only in the United 
States, but in other countries as well. In 2010, statistics showed that there were 15.5 
million opioid dependent people globally (Degenhardt et al., 2014). South Asia was 
identified as having the greatest number of opioid-dependent people (4 million), with East 
Asia, North Africa, and the Middle East, and Western Europe having 1.3 million each 
(Degenhardt et al., 2014). Studies have also indicated that people in higher income 
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countries continue to use opioids despite the significant impact it has on them socially, 
such as arrest and imprisonment for crimes related to theft of property and drugs, and the 
health problems that it causes, such as fatal and nonfatal opioid overdose (Degenhardt et 
al., 2014).   
Opioid is a pain analgesic that is very powerful and highly addictive (Dixon & 
Peirson, 2017). Some of the prescription drug classifications of opioid pain medication 
include oxycodone, hydrocodone, methadone, and morphine, which are used to treat short 
and long term pain and have been linked to the increasing drug overdose deaths in the last 
ten years (HHS, 2015). The death rate for drug poisoning from opioid pain medication has 
quadrupled from 1999 to 2013 (HHS, 2015).    
In the United States, addiction and abuse of opioid drugs continues to be a public 
health problem and a challenge. It affects approximately 5 million people and has led to 
nearly 17,000 deaths annually (Dixon & Peirson, 2017). The mortality rate from drug 
overdoses has continued to rise over the last twenty years and has been identified as the 
primary reason for injury mortality in the United States (HHS, 2015).    
In addition to mortality, there have been other adverse medical events linked to 
prescription opioid abuse over the last several years. There has been an increase in 
emergency room visits which were associated with abuse and misuse of prescription drugs 
with over 1.4 million pharmaceutical events, 420,000 involving prescription opioids 
(HHS, 2015). The literature has shown that people who are at the highest risks for opioid 
overdose are Alaskan Natives, White and American Indian men, adults between the age of 
45-54, people who live in rural areas who take daily high doses of opioid pain medication, 
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analgesics, and people who obtain several prescriptions for controlled substance from 
different providers (HHS, 2015).   
The misuse of prescription drugs continues to have a significant impact on 
communities throughout the country (Bureau of Justice Assistance [BJA], 2015). 
According to the CDC, this fatal prescription analgesic epidemic affects communities in 
every state (CDC, 2013). Communities are being targeted for criminal behaviors that are 
associated with prescription drug abuse and misuse, including home and business 
burglaries and robberies of pharmacies, clinics, and doctors’ offices. This has affected 
every community at the local, state, national and global levels necessitating interventions 
to help alleviate the drug dependency (BJA, 2015). It is clear that the impact of the misuse 
of opioids calls for immediate action. The significance of having a tool such as SOAPP, 
which helps identify potential opioid abusers, would provide useful knowledge for 
physicians to consider when developing a plan of care and treatment. Utilization of 
screening tools for opioids such as urine drug screen, opioid risk assessment screen, 
standardized pain scales, and prescription drug monitoring programs may assist in 
assessing those at risk of possible opioid abuse. Other barriers include time-constraints, 
lack of information, negative approaches toward prescribing opioids, and inadequate 
assessment skills (Harle et al., 2015). Pain management providers play a crucial role in the 
effectiveness and success of the patient’s treatment, and the use of such tools can assist in 
effective program planning to meet both the pain and addiction issues of the patient.   
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Purpose   
The purpose of this doctoral project was to introduce an evidence-based screening 
measure that will identify patients with the potential to abuse and misuse opioids into a 
pain management clinic practice for use with patients where it has been determined that 
the most effective treatment is the use of opioids to manage their chronic pain. This tool 
may assist clinicians in identifying patients who are at risk of addiction and alert the 
clinician to modify their treatment plan, if necessary. Identifying patients at risk for opioid 
abuse and/or dependence can alert the clinicians to provide education and intervention 
programs. The tool may further inform the provider of the need for alternative or modified 
pain management strategies. For patients who are identified as either abusing or misusing 
opioids, other strategies can be initiated, such as providerclient contracts, depression 
screenings, and monitoring of opioid use.    
The screening measure used for the patients in the study was the SOAPP, which is 
found in Appendix A (Inflexxion, Inc., 2008). SOAPP is a tool the clinician used to assess 
the potential that a patient would likely abuse opioids. SOAPP has 14 questions designed 
to predict behaviors of people using opioids for chronic pain. This screening measure 
complements current risk assessment practices and the clinician’s ability to assess patients 
risk for opioid misuse (Butler, Budman, Fernandez, Fanciullo, & Jamison, 2010). 
According to Butler et al. (2010), this tool is much more effective than other methods that 
are being used currently, and it gives the physicians an awareness that patients are at risks 
for deviant behaviors (Butler et al., 2010). The SOAPP should be used only with patients 
who have chronic pain and are being considered for long-standing opioid therapy. The use 
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of a broader base approach would not be applicable for all patients with chronic pain. This 
doctoral project has the potential to introduce a valid pain measurement tool to the 
healthcare community and add to the literature on evidencebased practice in pain 
management.   
Nature of the Doctoral Project   
This evidence-based practice project utilized the Rosswurm and Larrabee (1999) 
six stage model to facilitate a shift from traditional and intuition-driven practice to 
improvement with evidence-based changes into practice. The six stages of the model are 
as follows: (a) assess the need for a change in practice, (b) link the problem with 
interventions and outcomes, (c) synthesize the best evidence, (d) design a change in 
practice, (e) implement and evaluate the change in practice including processes and 
outcomes, and (f) integrate and maintain the change in practice using diffusion of 
innovation state strategies.    
Assess the Need for Change in Practice   
The physician and nurse practitioner manage a client load of approximately 1,226 
patients per quarter with chronic pain in a clinic located in an urban area of Indiana. They 
requested scholarly assistance in improving care by introducing an evidence-based 
screening instrument into the practice.   
This is a private practice setting primarily focused on musculoskeletal medicine 
and rehabilitation. The patient age range is from 30 to 80. The leading diagnoses are 
chronic low back pain, neck, hip and knee pain, fibromyalgia, and migraine. The majority 
of patients are treated with opioid medications to help aid in pain management. The 
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primary goal of the pain center is to restore maximum functioning lost through injury, 
illness or disabling conditions. The center treats numerous medical conditions and 
provides various treatment options, such as rehabilitation, pain management, alternative 
therapies, prolotherarpy, electrodiagnosis interventional procedures, and worker’s 
compensation and disability evaluation. The physician director is committed to the 
common good by helping clients achieve optimum pain management by addressing pain 
issues/concerns, screening, treating the individual as a whole and providing education, and 
offering alternative treatment and rehabilitation to help achieve a better quality of   
life.    
The primary aim of this study was to utilize assessment tools to identify clients 
who are at risk of opioid misuse or addiction and those who are currently misusing or 
abusing opioids and provide the most effective treatment plan to manage pain and avoid 
abuse. The misuse of opioids has been identified in the literature as one of the challenges 
of primary care practice (Harle et al., 2015).    
Link the Problem with Interventions and Outcomes   
Chronic pain and prescription opioid abuse continue to place a burden on society, 
patients, and doctors. (Sehgal, Manchikanti, & Smith, 2012). Over the last twenty years 
there has been a dramatic increase in chronic opioid use for treatment of noncancerous 
pain, which has resulted in a higher rate of abuse of prescribed opioids and unintentional 
overdose (Sehgal et al., 2012). A review of the literature suggests that using a validated 
screening tool can provide an additional method for managing patients on opioid therapy 
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and assist in addressing problematic issues as they occur. Recognizing and predicting risk 
could be of great benefit in reducing the risk of iatrogenic addiction (Sehgal, et al., 2012).   
One tool that has been utilized in screening during opioid therapy is the SOAPP. 
This tool can help doctors monitor any abnormal characteristic behaviors of misuse and 
abuse that are related to patients receiving opioid therapy for long term use for 
noncancerous pain (PainEDU, n.d.). According to Akbik et al., (2006) the SOAPP 
screening tool reveals factors such as history of substance abuse, legal problems, craving 
medications, heavy smoking, and mood swings that may indicate probability to misuse or 
abuse opioid medications (Akbik et al., 2006). The SOAPP instrument is a questionnaire 
which is simple and easy to use. It was designed based on important concepts that are 
likely to predict which patients on chronic opioid therapy will require additional or lesser 
monitoring. The questionnaire contains 14 items with a 5-point grading scale and takes 
less than eight minutes to complete. The SOAPP score risk is identified by the “cutoff 
values”: a score of 7 or greater identifies approximately 91% of those who are at high risk; 
a score less than 7 indicates a lower risk (Inflexxiion, 2008). Once the risk score is 
determined, the clinicians can identify which patients need more or less monitoring and 
can address concerns with the patients and update the plan of care with the appropriate 
interventions as indicated.    
The Pain Management Center of Brigham and Women’s Hospital tested the 
validity and reliability of the SOAPP tool using data collected from a group of chronic 
pain patients from five pain clinics across the country. The 24-item SOAPP tool, 
developed from the consensus of 26 pain and addiction experts, was administered to 175 
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patients who were taking opioids for chronic pain. Of the 24 items, 14 SOAPP items 
appeared to predict subsequent aberrant behaviors. Based on the reliability and predictive 
validity results, SOAPP was viewed as a promising screening risk potential tool for 
substance misuse among patients with chronic pain (PainEDU, 2016).    
Synthesize the Best Evidence   
According to PainEDU (2016), clinics often mention that they do not have an 
opioid risk assessment screening tool as part of their intake process. Due to the challenges 
with opioid abuse and misuse, clinics are finding that it is crucial to include an opioid risk 
assessment as part of their screening process. PainEDU has identified the   
SOAPP screening tool as an effective tool to incorporate as part of the intake process 
(PainEDU, 2016). The SOAPP tool was chosen to be used in this outpatient pain clinic 
due to the support in the literature and the significance of the design, which addresses the 
potential for opioid abuse or misuse. This tool helps clinicians improve their ability to 
assess patients’ risk for opioid abuse and can assist with the management of their 
treatment modality and plan of care (Butler et al., 2010).   
According to Butler et al. (2010), the sensitivity of a tool for screening may be 
more important than the specificity because those screened might have problems 
managing their medications. Butler et al. suggests that medical decisions not be made 
merely on basis of the SOAPP screening, however.    
Design a Change in Practice   
The SOAPP screening tool was used with new admissions and routine visits by 
established patients. The SOAPP questionnaire was given orally to 100 consecutive 
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patients in a private setting. The data was scored according to their answers in nominal 
ratio. The patients who were identified as high risk were recommended for close 
monitoring by the clinicians and a review of their plan of care.    
Implement and Evaluate the Change in Practice Including Processes and Outcomes   
For a period of two weeks, the investigator reviewed charts of patients on the 
appointment list for the following day. Those with a medical diagnosis of pain and 
currently taking opioids had the survey tool attached to their intake form. The patients 
were requested to complete the form prior to seeing the physician.   
The tool was reviewed by the investigator and a score placed on the chart to alert 
the clinician. Results were collected for a total of 100 patients in a table for descriptive 
statistics. Participants were not identified by name; rather, each was assigned a unique 
identifier for the data analysis. The clinician indicated on the summary tool whether the 
tool influenced the plan of care. This information was used to determine the impact on 
clinician behavior.   
The descriptive data analysis included patients between the ages of 25 and 65 who 
were receiving opioid medication for noncancer pain. This analysis will be used for health 
planning purposes regarding the education and promotion of interventions for patients 
with the potential for opioid abuse (Friis & Sellers, 2014).   
Integrate and Maintain the Change in Practice Using Diffusion of Innovation State 
Strategies    
Once the data was obtained from the SOAPP questionnaire, the scores were 
calculated and analyzed as being a low or high risk for opioid misuse or abuse. The 
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physician or the nurse practitioner was notified in person. The results and identifiable 
interventions and plan of care were addressed with staff identified as key stakeholders.   
Significance   
The potential implication for this project is to introduce the utilization of a reliable 
tool to assess a patient’s risk of potential abuse or misuse of opioids as part of the 
development of pain measurement and an individualized plan of care for pain 
management. Once this tool is implemented, the clinicians can review the medication and 
adjust the plan of care accordingly. Positive social change will result from identifying at 
risk patients, which may help reduce the potential for opioid misuse and abuse.   
Summary   
The lack of evidence-based pain measurement tools and the shortage of physicians 
specializing in pain management has contributed to ineffective opioid prescribing 
practices and to misuse and abuse of opioid medication (Harle, et al., 2015). The 
incorporation of the SOAPP pain measurement tool into a chronic pain practice has the 
potential to facilitate the providers’ decision making and clinical management of chronic 
pain patients. In Section 2 I will detail the concepts, theories, and the change model and 
provide additional literature on the employment of the SOAPP tool with opioid use.   
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Section 2: Background and Context   
Introduction   
This evidence-based practice project introduced the use of the SOAPP 
questionnaire in identifying chronic pain patients who are either at risk of or currently 
abusing or misusing opioids. Pain is one of the major causes of disability, work loss, and 
health care costs in the United States (Hayden et al., 2012). The purpose of this project 
was to introduce a reliable pain measurement tool to facilitate providers in developing an 
individualized plan of care for pain management.   
Published Outcomes and Research   
The databases and search engines that were used in the literature search included 
the Cochrane Database, Ovid Nursing, CINANL, SAGE, MEDLINE, and Google   
Scholar. The key search terms used were opioid abuse and misuse, pain management, 
SOAPP, overprescribing, prescription drugs, opioid screening tools, federal and state 
guidelines, nursing role in pain management, Roy Adaptation Model, the CDC website, and 
fact sheets from the National Institutes for Mental Health.   
The literature reviewed was published within the last five years, and the sources 
included Journal of American Medical Association, American Academy of Pain   
Medicine, Pain Physician, Institute of Medicine, The Annual Review of Public Health,   
Nurse Practitioner Healthcare Foundation, Journal of Pain and Symptoms, PubMed   
Central, Journal of Addiction Medicine, U.S. Government Fact Sheets, and the American 
Journal of Nursing. This search resulted in a comprehensive review of the literature to 
address the practice focus question.   
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Drug abuse and addiction is a major social and global health problem. One factor 
is the treatment of pain. In the United States, there are approximately 100 million   
Americans who suffer from chronic pain (Why do people get addicted to opioids?, 2016). 
The increase has occurred over a 25-year period from nearly 75 million in the 1990s to 
nearly 206 million in 2013 (Zimic & Jukic, 2012). Other factors contributing to this 
problem are family risk factors, childhood experiences, family boundaries, and social 
influence by peers, friends, schools, and surrounding environments (Georgas, Berry, van 
der Vijver, Kagitçibasi, & Poortinga, 2006).   
Some professionals believe the prescription painkiller problem in the United 
States is the result of opioids being prescribed in combination with other medications, 
along with the influence of pharmaceutical advertisements. For some, drug abuse begins 
with a prescribed opioid for a valid medical reason and then feelings of relief lead to the 
enraptured effect of the drug (Why do people get addicted to opioids? 2016). The dangers 
of abuse can occur from the use of all forms, such as pills taken orally, snorting, injecting, 
or a combination of pills and alcohol with other drugs. Additionally, many people in the 
community are going from prescriptive opioid abuse to the use of heroin. Scientists 
believe the physical changes to the brain explain the neurotic and damaging behavior of 
individuals addicted to opioids. When tolerance to these drugs begins to function as a 
normal process, the body is unable to control the impulses needed to mitigate harsh 
consequences (Why do people get addicted to opioids? 2016).   
With the ongoing trend of opioid abuse and misuse, it is essential that monitoring 
programs be put in place to help reduce the problem. According to Irvine et al. (2014) 
16   
   
 
prescription drug monitoring programs (PDMPs) are relatively new but are a helpful tool 
to aid in the management of prescribed controlled substances. There appears to be little 
known about the kinds of clinicians who make the most use of PDMPs, how they are 
integrated into the work process, or how clinicians and patients react to evidence. More 
inquiry is necessary to lessen prescription abuse of drugs and overdoses, which have 
become widespread in the United States, and to explore the potential for the 
implementation of PDMP to offset the epidemic (Irvine et al., 2014).   
A statewide survey was conducted with approximately 1,000 providers, which 
consisted of clinicians from primary care and emergency rooms as well as pain and 
addiction specialists. The primary goal was to see how clinicians make use of the PDMPs, 
how the data is incorporated into the work place, and how the patients and clinicians 
respond to the information. This survey revealed that almost 90 percent of clinicians 
reported using the PDMP when they suspected a patient of diversion or abuse. However, 
less than half would check every new patient or when they prescribed a controlled 
substance. Approximately 50% of patients were referred to substance abuse and mental 
health clinics, and about 30% were discharged from the clinician’s practice (Irvine et al., 
2014). The survey also identified that clinicians reported a range of patient behaviors such 
as denial and anger, and almost three quarters of the patients did not come back. Some 
patients did ask for help with dependence and drug addiction. At least 61% of clinicians 
thought more training in PDMP would be useful in identifying abuse of substances and 
provide different ways to control medications, strategies for confrontation diffusion, and 
methods of chronic pain management (Irvine et al., 2014).   
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According to Irvin et al., (2014) physicians who used PDMP for any reason found 
that through interviews, the tool served as a means of communication between patient and 
providers. This enhanced the opportunity for dialogue regarding topics of education, 
compulsion, dependence, and ways and approaches to improve pain management. In one 
physician’s summation, this tool has a ways to go in terms of helping to find out what is   
the best way to make decisions and combining them into a process (Irvin et al., 2014).   
Concepts, Models, and Theories   
Rosswurm and Larrabee’s (1999) model of change represents a shift from the 
traditional way nurses practice to implementing the new paradigm of evidence-based 
practice in the clinical setting. Evidence-based practice is a model which guides 
practitioners through research literature and theory. According to Institute of Medicine 
(IOM) the way nurses were taught in the 20th century is no longer adequate for the health 
care in the 21st century (IOM, 2010). The patients have become more complex and require 
a higher standard of care. Nurses’ roles will expand to managing information systems and 
mastering technological tools while coordinating and collaborating care across teams of 
health providers. The nurse must achieve higher levels of education that is research and 
evidence-based and develop competence in leadership, health policy, system 
improvement, and collaboration (IOM, 2010).    
This model of care integrates the process of change through assessment of needs 
and adoption of new protocols that are evidence-based to minimize the discomfort 
clinicians and patients experience when it comes to questions, data, preferences, and new 
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research (Rosswurm & Larrabee, 1999). These identifiable changes can help stakeholders 
become aware of potential changes that are needed to achieve the best outcome   
(Rosswurm & Larrabee, 1999).   
There have been significant changes in today’s health care systems’ focus on 
integrating evidence-based practice into health care to help improve patient safety, care, 
and cost containment while providing a better outcome. Also, research has identified that 
with the diversity of patient’s needs, it is critical that nurses be prepared to function as a 
leader and advance science that benefits patients and improves the capacity of the health 
professional to deliver safe, effective, and patient-center care (IOM, 2011).   
Relevance to Nursing Practice   
Over the past 20 years the prevalence of chronic pain and the rising costs of 
healthcare have contributed to an opioid epidemic with serious consequences to morbidity, 
mortality, and crime levels (Manchikanti et al., 2012). There are more deaths from opioid 
analgesics than from motor car crashes, suicides, and heroin and cocaine combined 
(Manchikanti et al., 2012). There is a significant relationship between the sale of opioid 
pain relievers and the rise in deaths. However, deaths are almost 60% in patients with 
prescriptions based on guidelines by medical boards and nearly 40% in the form of 
numerous prescriptions, doctor swapping, and drug diversion (Manchikanti, et al., 2012). 
Obstacles to preventing opioid deaths include insufficient knowledge, safety perceptions, 
and incorrect beliefs regarding handling of pain by clinicians.    
According to the AAOS (2015), opioid overdose is now the leading cause of 
accidental death in young adults and contributes to a greater risk of postoperative 
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expiration. The AAOS suggests that surgeon and members of the team should explain to 
extended families and patients, that opioid protocols cannot be violated and that there 
should be better control established.    
However, the diversion tactics of opioids from friends and family members who 
have appropriate prescriptions are a major part of the abuse of prescribed opioids (AJN, 
2015). Nurses are considered trusted and influential in educating the family to help 
decrease the occurrence and possibilities of deadly consequences of prescription opioids.    
The advanced nurse practitioner and clinic nurses have a role in reducing opioid 
diversion through patient monitoring, screening, education and alternative medications 
(AJN, 2015). There are large gaps in knowing how much opioid medication is needed to 
help manage a patient’s pain. Nurses are at the forefront and have the opportunity to 
provide clients with strategies that involve patient education on the dangers of diverting 
medication to other areas, securing, disposing and monitoring efforts to help reduce their 
availability of opioid medications (AJN, 2015).   
The practice improvement project introduces an opioid screening tool, the Screener 
and Opioid Assessment for Patients with Pain (SOAPP). The clinic population where this 
tool was used is representative of the many patients seeking treatment for pain in the 
musculoskeletal area of the body and restoration of functions lost due to injury, sickness, 
or debilitating conditions. For these patients treated with opioid medications, the SOAPP 
screening will help focus on identifying the patients who could be misusing or becoming 
addicted to opioids.   
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According to Moore, Jones, Browder, Daffron and Passik, (2009), substance abuse 
has a negative impact on society and does affect millions of people in the United States. 
Prescriptive opioids are critical to managing pain, therein lies a fear that aberrant drug 
associated behavior, addiction and abuse are reasons why under treatment of some cancer 
patients is prevalent (Moore et al., 2009).   
A survey by Moore et.al, (2009) used a sample of patients 18 years and older in the 
study of females and males using a risk assessment by completing a questionnaire, with 
the SOAPP, Opioid Risk tool (ORT), the Diagnosis, Intractability Risk, and Inventory 
(DIRE), and a team psychologist. Several pain management centers measure risk by using 
only one of the evidence-based tools to predict and conclude probable risk of abuse when 
recommending opioids for pain (Moore et al., 2009).   
According to Butler (2009), the SOAPP assessment tool helps provide information 
on how much monitoring is needed or required based on the cut-off score predictor. The 
SOAPP value proposition is that there is sensitivity in the test. In subsequent studies, the 
SOAPP is better at the identification of high risk patients rather than the identification of 
who is at low risk (Butler, 2009). Moore et al. (2009) noted that the cut-off score which 
measured participants” greater than 6 on the SOAPP, or less than 14 on the DIRE, were 
considered high risk, whereas, scoring from 4-7 or greater than 7 on the ORT were 
considered medium and high risk, respectively” (Moore et al., 2009).   
Moore et al. (2009) compared three tools of assessment for predicting aberrant 
behaviors and whether validation can result in opioid medications suspension. The 
SOAPP was rated the best of the screening tools with its specifics of behavior, length, and 
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opacity and the high sensitivity and values of these measures. This tool was noted to be 
very useful when it came to time of completion and management of a large volume in the 
clinical site, which can help with patient and staff load (Moore, 2009). The authors did 
note that the study was small and more research is needed to make a knowledgeable 
choice over another when determining specific treatment approaches and medical 
techniques to help with treatment (Moore al et., 2009).   
Summary   
There is a need to include reliable pain measurement tools to facilitate providers in 
developing an individualized plan of care for management. Opioid abuse crosses all ages, 
ethnic groups, economic situations, and education levels. Evidence-based practices and 
protocols require adherence to reach the ultimate goal and foster a plan to eradicate the 
social, psychological, health and economic hardship of opioid abuse.   
According to American Association of Colleges of Nursing (AACN) Essentials, 
the advanced nurse practitioner must utilize evidence based knowledge to the highest 
standard of practice to facilitate change effectively to benefit patients’ daily needs and 
provide for a better outcome (ACCN, 2006). The role of the DNP encompasses the role of 
practitioner, educator, and activist for the purpose of implementing change in the 
community. Section two will provide additional detail on the implementation and data 
analysis plan.     
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 Section 3: Collection and Analysis of Evidence   
Introduction   
There has been an increase in abuse and misuse of prescription drugs for chronic 
pain patients in the Untied States (Manworren & Gilson, 2015). Overprescribing of 
opioids for pain management has contributed to a noticeable increase in opioid addiction 
and death caused by overdose and heroin use (Kolodny et al., 2015). According to Reuben 
et al. (2015), over 100 million people in the United States suffer from chronic pain. A 
suspected 70% of those individuals treated their pain with opioids prescribed to a friend or 
family member (Arnstein &St. Marie, 2010). The shortage of physicians specializing in 
pain management has contributed to ineffective opioid prescribing practices and either 
misuse or abuse (Harle et al., 2015). The purpose of this project was to implement an 
evidence-based screening measure for opioid abuse and misuse for chronic pain patients 
who take opioids to manage their pain.    
Practice-Focused Question   
The practice focused question was: Does the utilization of an evidence-based 
screening tool assist the clinician in an out-patient pain management setting in identifying 
chronic pain patients who are either at-risk of or who are abusing or misusing opioids, and 
does it result in a modification of routine therapy?   
Sources of Evidence   
The collection and analysis of evidence from the SOAPP screening tool scores 
patients who are at risk for opioid misuse, thus alerting the clinician to monitor patients 
more closely. According to Butler et al., (2010), a cross-validation study was conducted 
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and showed that the SOAPP tool was a reliable and valid screening tool to use for the risk 
of aberrant drug-related behavior among patients with chronic pain (Butler et al., 2010). 
SOAPP was developed with a grant from the National Institutes of Health and an 
educational grant from Endo Pharmaceuticals (Inflexxion, 2008). It was designed based on 
an expert consensus model to help clinicians identify those patients that may require more 
or less monitoring while on opioid therapy. The SOAPP is a self-report measure that 
consists of 24 items, but only 14 are used for scoring. The scoring is based on a   
Likert 5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4 (Very Often). 
The cut-off value is 7; the score of 7 or above indicates a high risk for abuse and the need 
for additional monitoring for treatment for opioid therapy (Akibik et al., 2006). A study 
conducted with 48 participants in Tennessee by Moore, Jones, Browder, Daffron, and 
Passik, (2009) compared three common risk tools for predicting at-risk aberrant 
drugrelated behavior; the ORT, DIRE, and SOAPP. The study concluded that the SOAPP 
was more sensitive in identifying high-risk aberrant behavior, required less time to 
complete, and took only one minute to score, making it a very practical screening tool to 
use, even for large clinical settings.   
Evidence Generated for the Doctoral Project Study Design   
The study was a quantitative descriptive study using a convenience  
sample population which included all new and established patients who were prescribed 
opioid medications for noncancer pain. The patients who were prescribed opioid 
medication were screened to see if the opioid risk assessment tool was effective in 
identifying an atrisk population for opioid abuse and misuse and provided useful 
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information for the clinician’s management plan in this outpatient pain management 
clinic. The exclusion criteria was anyone under the age of 18, those with an altered mental 
status, anyone having the inability to speak English, and those who were not currently 
taking opioid medications.   
Setting and Sample   
The setting was an outpatient pain clinic with designated private rooms for 
providing the questionnaire. The questionnaire was given to the patients prior to the 
clinicians entering the room. The participants were selected from an established outpatient 
pain clinic; therefore, all patients were taking opioid medications. The sample size 
consisted of 20% of the monthly population of 500, which resulted in a sample size of n = 
100. The sample included both males and females between the ages of 25 and 65 who met 
the requirement of short- and long-term opioid use for noncancerous pain.   
Data Collection   
The data collection method was a SOAPP questionnaire that consisted of 14 
questions. The questionnaire addresses history of alcohol or drug abuse, craving of 
medication, mood swings, legal problems, and smoking (Akbik et al., 2006).   
Procedures   
I took the day’s scheduled appointments and performed a medical chart review on 
adult patients between the ages of 30 and 65 who were currently prescribed opioid 
medications. Charts were flagged so the intake staff knew to alert me to do a screening 
interview with the patient using the SOAPP questionnaire. The score and results were put 
into the patient chart for the physician to review. There was a separate card that the 
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physician completed noting the score of the SOAPP and whether this information actually 
modified the plan of care, either through alternative prescribing, detailed education, or a 
monitoring plan.   
Protections   
 While study participants were identified by their name in the chart, this was held 
in strict confidence. All questionnaires were conducted in the exam room to ensure 
confidentiality, and the data was limited to the physician and nurse practitioner. The data 
form from the physician noting the score and whether they modified the plan of care did 
contain identifying information. I used this information to construct a database for analysis 
using descriptive statistics. This practice improvement project is adding to the normal 
assessment of patients in this particular practice for use by the physician and therefore did 
not require the patient’s consent. This proposal was submitted to the IRB  for approval 
(approval # 01-13-17-0533125).   
Analysis and Synthesis   
The analysis and synthesis of evidence addressed the practice focused question of 
whether the use of the SOAPP screening was helpful for clinicians in identifying patients 
who were at risk for aberrant behavior associated with receiving opioids to manage their 
pain. The system used to record the data that was obtained from the SOAPP questionnaire 
was the eClinicalWorks 10. The eClinicalWorks 10 is an electronic medical record that is 
used in this practice for daily operations. This system allows data to be stored in a safe and 
secure place and only accessible by individuals with a secure user ID and password.  
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The data was scored using the Likert Scale of 0 = Never, 1= Seldom, 2 = Sometimes, 3 = 
Often, 4 = Very Often, to determine if the patients were at low or high risk for opioid misuse 
or abuse. Once the summary of the score was obtained, the results were placed in 
eClinicaWorks 10 secure notes for review or modification of their plan of care. The secure 
notes are only accessible to the physician and the nurse practitioner who are currently 
managing their pain. The questionnaire was given orally and scored by me to help minimize 
errors and missing data.   
Summary   
The main focus of this study was to explore the use of evidence-based practice 
tools to address the process of solving the problem of opioid abuse and misuse by 
patients. The study may provide additional information in the identification of risks for 
those who are receiving prescribed medication from a physician or nursing practitioner. 
Opioid abuse is not only a patient problem but a problem for all of society due of the 
extreme nature of events that have occurred from overprescribing of opioids and the toll it 
has taken on families and within communities. Section 4 will detail the findings and 
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Section 4: Findings and Recommendation   
Introduction 
There has been an increase in abuse and misuse of opioid prescriptions by chronic 
pain patients in the Unied States (Manworren & Gilson, 2015). Overprescribing of  
opioids for pain management has contributed to a noticeable increase in opioid addiction 
and death caused by overdose and heroin use (Kolodny et al., 2015). The shortage of 
physicians specializing in pain management has contributed to ineffective opioid 
prescribing practices and either misuse or abuse (Harle et al., 2015). The practice focused 
question for this study was: Does the utilization of an evidence-based screening tool assist 
the clinician in an out-patient pain management setting in identifying chronic pain patients 
who are either at-risk of or who are abusing or misusing opioids, and does it result in a 
modification of routine therapy? The purpose of this project involved the need to 
implement evidence-based screening measures for opioid abuse and misuse for chronic 
pain patients who take opioids to manage their pain.   
The data collection method was the SOAPP questionnaire that consists of 14 
questions. The questionnaire addresses history of alcohol or drug abuse, craving of 
medication, mood swings, legal problems, and smoking, (Akbik et al., 2006). The scoring 
is based on a Likert-5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4 
(Very Often). The cut-off value is 7; the score of 7 or above indicates a high risk for abuse 
and the need for additional monitoring for treatment for opioid therapy (Akibik et al., 
2006).    
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SOAPP was developed with a grant from the National Institutes of Health and an 
educational grant from Endo Pharmaceuticals (Inflexxion, 2008). It was designed based on 
an expert consensus model to help clinicians identify those patients who may require 
monitoring while on opioid therapy.    
One hundred consecutive patients who presented at the medical practice were adult 
patients between the ages of 25 and 65 who were currently prescribed opioid medications. 
The SOAPP questionnaire was orally presented to the patients by this author at the time of 
their scheduled appointment and prior to the clinicians entering the room. The results were 
scored using a Likert 5-point scale of 0 (Never), 1 (Seldom), 2 (Sometimes), 3 (Often), 4 
(Very Often). The cut-off value is 7; anything below 7 is considered low risk and the score 
of 7 or above indicates a high risk for abuse and does require additional monitoring for 
treatment for opioid.    
Finding and Implications   
The data collected from the SOAPP screening assessment tool found that 25% of 
the interviewed participants scored at high risk (over the 7 cut-off value) for opioid misuse 
and may require additional monitoring by the physician and nurse practitioner. The 
patients identified as high risk were recommended for close monitoring by the clinician 
and the results were used to aid in the development of a treatment plan that would avoid 
the use of addictive interventions that could promote misuse. Findings were consistent 
with Butler (2010) in regards to the SOAPP tool being an effective tool in identifying 
patients at risk for abuse and providing awareness so problems can be addressed.   
29   
   
 
The descriptive analysis includes both males and females between the ages of 25 
and 65. The mean age for high risk was 51 and for low risk 54. Twenty two percent (22%) 
of females and 27% of males scored at high risk. When divided into age groups, risk 
appeared to increase with age in males and females, although the low number of 
participants by age group is not statistically significant. This is consistent with the HHS  
(2015) statistics noting that those aged 45-54 were at highest risk for opioid abuse.   
   
Table 1   
Patients Scoring Over 7 by Age and Sex   
   
Categories      
Number of persons 
in this category   
Number scoring 7 
and above   
Percentage scoring   
7 and above   
Male <35   7   1      14%   
Male 36-49   17   5   
   
 29%   
Male >50   31   9     29%   
Female <35      2   2     100%   
Female 36-49   13   2    15%   
Female >50      30   6    20%   
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A review of individual questions showed that the most significant questions that 
pointed to risk factors were related to addictive behaviors, family history, and drug 
screening. Table 2 provides information on those ranking at risk by question.   
Table 2   
Percentage Scoring 7 (n = 25) and Above by Individual Question    
 
Questions       Percentage Average Response 7 and above   
1. How often do you have mood swings?   88%     
2.  How often do you smoke a cigarette within an 
hour after you wake up?      
84%   
   
   
3.  How often have any of your family members,  
including parents and grandparents, had a problem 
with alcohol or drugs?        
56%   
   
   
   
   
4.  How often have any of your close friends had a 
problem with alcohol or drugs?     
40%   
   
   
   
5.  How often have others suggested that you have a 
drug or alcohol problem?      
16%   
   
   
6.  How often have you attended an AA or NA 
meeting?            
32%   
   
   
7.  How often have you taken medications other than 
the way that it was prescribed?        
16%   
   
   
8.  How often have you been treated for an alcohol 
or drug problem?   
24%   
   
   
9.  How often have your medications been lost or 
stolen?   
2%   
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10. How often have others expressed concern over 
your use of medication?   
12%   
   
   
11.  How often have you felt a craving for 
medication?   
12%   
   
   
12.  How often have you been asked to give a urine 
screen for substance abuse?   
60%   
   
 
   
13.  How often have you used illegal drugs (for 
example, marijuana, cocaine, etc.) in the past five 
years?     
32%   
   
   
   
14.  How often, in your lifetime, have you had legal 
problems or been arrested?       
52%   
   
   
   
A more detailed analysis of the four top questions in Table 3 revealed these 
questions were more strongly associated with both males and females over 50. Further 
study is needed on other factors such as longevity of opioid use and the acuity of chronic 
pain in older adults.    
   
Table 3   
Percent at Risk by Question, Sex, and Age   
Question   Males 
<35   
Males 
36-49   
Males 
>50   
Femal 
es <35   
Femal  Femal  
es 3649  es 50>   
Mood Swings   
Cigarette within an 
hour of waking up   
4%   
4%   
20%   
20%   
24%   
32%   
8%   
8%   
8%   24%   
8%   12%   
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Family Members with 
substance abuse  
issues   
4%   4%   20%   4%   4%   20%   
Urine drug screen   4%   12%   20%   8%   4%   12%   
   
Patient Response   
I found that the patients were receptive to the score outcome whether it was high or 
low. Many patients agree with the score and were not really surprised with their results. 
However, the MD was surprised at some of the results. The implication for this practice is 
that the introduction of a reliable tool to assess a patient’s risk of potential abuse or misuse 
of opioids can aid in the development of an individualized plan of care for pain 
management. The findings increased the awareness of potential risk to the nurse 
practitioner (NP) and MD, resulting in their altering the plan of care of all those who 
scored high risk. Modifications included more frequent visits, medication logs, and 
intermittent urine testing.   
The results from the screening tool can be used to educate the patient on risk 
factors of opioid abuse and allow the patient to become more involved in their plan of 
care. Patient involvement provides an opportunity for them to contribute to the 
effectiveness and success of their pain management treatment plan. This office will 
continue to utilize this tool in their practice.   
The significance of using a simple screening tool such as SOAPP can have a 
positive impact on social change by reducing opioid abuse and, in the long run, prevent 
aberrant drug associated behavior. The misuse of prescription drugs continues to have a 
significant impact on communities throughout the country (BJA, 2015). Communities are 
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being targeted for criminal behaviors that are associated with prescription drug abuse and 
misuse, including home and business burglaries and robberies of pharmacies, clinics, and 
doctors’ offices. This has affected every community on the local, state, national, and 
global level, necessitating interventions to help alleviate the drug dependency (BJA,   
2015).    
The implications for nursing practice include the utilization of screening tools by 
the nurse practitioner who sees patients with chronic pain and the inclusion of patients into 
the discussion of risk and the plan of care. Nurses need to be informed about the risks of 
opioid use and addiction potential. The goal is to provide optimal pain management while 
addressing the issues that may lead to addiction.   
Recommendations   
Several pain management centers measure risk by using only one of the 
evidencebased tools to predict and assess probable risk of abuse when recommending 
opioids for pain (Moore et al., 2009). It is recommended that risk assessment screening 
tools be used on a regular basis in combination with cross-validation. For example, the 
SOAPP results indicating a patient is at high risk of abusing opioids can be compared with 
the patient’s urine results to validate the patient is currently misusing or abusing opioids. 
This author recommends that the patients be included in the discussion of the results to 
make them aware of their potential risk of opioid abuse or misuse and involve them in 
their plan of care.   
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Strength and Limitations of the Project   
The major strength of this project is that the SOAPP instrument is a questionnaire 
which is simple, free and easy to use and takes less than eight minutes to complete and 
only one minute to score. This makes it a very practical screening tool to use, even for 
large clinical settings. It is voluntary and non-invasive. The truthfulness and honesty of the 
patient’s responses has an impact on the validity of the findings and is a limitation to using 
this screening tool alone. This study did not allow for comparison of the SOAPP tool 
results with urine screenings, or other screening methods which would have strengthened 
the findings. The SOAPP screening tool should not only be used with patients who are 
being considered for long-standing opioid therapy for chronic pain. It could be used in 
other settings such as hospitals or primary care physician offices. It can be used for other 
prescribed addictive medications. Additional research utilizing the took  
with cross validation measures is needed.      
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Section 5: Dissemination Plan   
The dissemination plan for this private practice pain management clinic is that I 
will give an oral presentation to the nurse practitioner and physician. Any high-risk 
patients will have their treatment and plan of care monitored more closely to help avoid 
the potential for misuse or abuse. The SOAPP questionnaire that was used in this project 
to identify low or high risk patients will be scanned into a secure file for storage. I plan to 
submit my abstract to National Institute on Drug Abuse regional meeting.   
Analysis of Self   
As a nurse practitioner, I have learned to be a strong advocate for change. And, as 
an advocate and implementing change, I can have a significant impact on our society. I 
can increase the chances of a patient having a better quality of life by incorporating 
evidence-based research, recommendations, and guidelines that have been scientifically 
proven to be beneficial. As a scholar, I have learned that a holistic approach to everyday 
practice should be used to monitor and treat patients based on individual need 
assessments.   
This practical experience has given me a wealth of knowledge as a researcher, but 
it has also had an impact on my personal and professional growth. It has allowed me 
insight on a first-hand basis into situations that have been experienced by people in real 
life. This has enlightened and refocused my long-term professional goals of opening a 
much-needed rehabilitation center in a rural setting for people who are unable to afford the 
help they desperately need due to cost and availability.   
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As with most projects, there are challenges such as finances, transportation, 
honesty, manipulation, noncompliance, and education. People in the healthcare profession 
must face the challenges with integrity, knowledge, and available resources, and try to 
treat everyone with dignity and respect. Although I may not have traveled the roads others 
have traveled or encountered their struggles, as a professional, I promise to be a strong 
leader, advocate, educator, resource, therapist, and nurse practitioner who is willing to 
make a difference through change, caring, and hope.    
Summary   
With the ongoing trend of opioid abuse and misuse, it is essential that monitoring 
programs be put in place to help reduce the problem. These monitoring programs can help 
physicians and nurse practitioners become more aware of patients who may have 
difficulty controlling their own medical use of opioids and who may require more 
monitoring and management to avoid the potential for abuse or misuse of opioids today.   
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Appendix A: Screener and Opioid Assessments for Patients with Pain (SOAPP)   
   
SOAPP VERSION 1.0-14Q   
   
   
 Name: ___________________________________________ Date: _______________     
   
The following are some questions given to all patients at the Pain Management Center 
who are on or being considered for opioids for their pain.  Please answer each question 
as honestly as possible.  This information is for our records and will remain 
confidential.  Your answers alone will not determine your treatment.  Thank you.     
   
Please answer the questions below using the following scale:      
   
0 = Never, 1 = Seldom, 2 = Sometimes, 3 = Often, 4 = Very Often   
   
   
1. How often do you have mood swings?              
   
2. How often do you smoke a cigarette within an hour after   
0   1   2   3   4     
     you wake up?                        
   
3.  How often have any of your family members, including parents   
0   1   2   3   4   
     and grandparents, had a problem with alcohol or drugs?        
   
4.  How often have any of your close friends had a problem with   
0   1   2   3   4   
     alcohol or drugs?                      
   
5.  How often have others suggested that you have a drug or   
 0   1   2   3   4    
     alcohol problem?                      
   
0   1   2   3   4   
6. How often have you attended an AA or NA meeting?         
   
7. How often have you taken medication other than the way that it   
 0   1   2   3   4   
     was prescribed?                        0   1   2   3   4   
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      0 = Never, 1 = Seldom, 2 = Sometimes, 3 = Often, 4= Very Often   
   
   
8. How often have you been treated for an alcohol or drug problem?     0   1   2   3   4   
   
9. How often have your medications been lost or stolen?           0   1   2   3   4   
   
10. How often have others expressed concern over your use   
       of medication?                           0   1   2   3   4   
   
11. How often have you felt a craving for medication?          0   1   2   3   4   
   
12. How often have you been asked to give a urine screen   
       for substance abuse?                     0   1   2   3   4   
   
13. How often have you used illegal drugs (for example, marijuana, cocaine, etc.) in the 
past five years?       0   1   2   3   4   
   
14. How often, in your lifetime, have you had legal problems or   
       been arrested?                         0   1   2   3   4      
   
   
   
   
   
Please include any additional information you wish about the above answers. Thank you.   
(Inflexxion, 2008).   
   
©2008 Inflexxion, Inc.  Permission granted solely for use in published format by 
individual practitioners in clinical practice. No other uses or alterations are authorized or 
permitted by copyright holder.  Permissions questions: PainEDU@inflexxion.com. The 
SOAPP® was developed with a grant from the National Institutes of Health and an 
educational grant from Endo Pharmaceuticals.    
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